Prior to joining Veeda, Bhalgat was heading operations of Syngene International, India’s largest contract research, development and manufacturing organisation as chief operating officer.
Mahesh has vast experience of being in senior leadership roles in Amgen, Sanofi and Biological E.
“The joining of Mahesh (Bhalgat), a highly accomplished Pharma-Biotech industry veteran reflects the strong commitment across the group companies to becoming a leading Contract Research Group, by expanding footprint beyond India and offering comprehensive set of research services for diverse clients serving both early and late-stage global clinical development programs,” Vivek Chhachhi, board member and director at Veeda Clinical Research.
“He will focus on business growth, including mergers and acquisitions, leveraging technology and client centricity to bring the best of Veeda’s service portfolios to the global clients,” Chhachhi added.
Veeda offers a range of bioequivalence studies and early and late phase clinical trials.
